SPDR SSGA US Large Cap Low Volatility Index ETF (ARCA: LGLV)

Latest News for SPDR SSGA US Large Cap Low Volatility Index ETF (ARCA:LGLV)

SPDR SSGA US Large Cap Low Volatility Index ETF

SPDR Russell 1000 Low Volatility ETF

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Mizuho raised the price target for LyondellBasell Industries N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) from $98 to $108. Mizuho analyst Christopher Parkinson maintained a Neutral rating. LyondellBasell shares rose 2.5% to close at $102.13 on Friday. <a href="https://www.benzinga.com/quote/LYB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup boosted the price target for Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) from $93 to $105. Citigroup analyst Tyler Radke upgraded the stock from Neutral to Buy. Shopify shares rose 1.1% to close at $71.33 on Friday. <a href="https://www.benzinga.com/quote/SHOP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities increased Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) price target from $90 to $100. B of A Securities analyst Bryan Spillane maintained a Buy rating. Colgate-Palmolive shares rose 1.9% to close at $91.01 on Friday. <a href="https://www.benzinga.com/quote/CL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity raised the price target for Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) from $9 to $10. Canaccord Genuity analyst Brian McNamara maintained a Buy rating. Newell Brands shares rose 12.3% to close at $7.79 on Friday. <a href="https://www.benzinga.com/quote/NWL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt cut Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) price target from $297 to $292. Rosenblatt analyst Barton Crockett maintained a Neutral rating. Charter Communications shares fell 1.7% to close at $254.61 on Friday. <a href="https://www.benzinga.com/quote/CHTR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer increased DoorDash, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) price target from $140 to $150. Oppenheimer analyst Jason Helfstein maintained an Outperform rating. DoorDash shares rose 3.1% to close at $132.11 on Friday. <a href="https://www.benzinga.com/quote/DASH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Susquehanna cut the price target for Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) from $200 to $185. Susquehanna analyst Christopher Rolland maintained a Positive rating. AMD shares gained 2.4% to close at $157.40 on Friday. <a href="https://www.benzinga.com/quote/AMD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays cut Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) price target from $546 to $395. Barclays analyst Adrienne Yih downgraded the stock from Overweight to Equal-Weight. Lululemon shares rose 1.3% to close at $364.70 on Friday. <a href="https://www.benzinga.com/quote/LULU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. boosted Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) price target from $250 to $300. HC Wainwright &amp; Co. analyst Mike Colonnese maintained a Buy rating. Coinbase shares rose 5.7% to close at $236.32 on Friday. <a href="https://www.benzinga.com/quote/COIN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies slashed Southwest Airlines Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) price target from $28 to $20. Jefferies analyst Sheila Kahyaoglu downgraded the stock from Hold to Underperform. Southwest Airlines shares fell 0.8% to close at $27.03 on Friday. <a href="https://www.benzinga.com/quote/LUV/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38485545/top-3-real-estate-stocks-that-are-set-to-fly-in-april">Top 3 Real Estate Stocks That Are Set To Fly In April</a>

News

Price Target

Markets

Trading Ideas

CHTR

COIN

DASH

LULU

SHOP

Coinbase Global To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Monday

WIIM

CNDT

Conduent shares are trading higher after the company announced an innovation initiative with Microsoft that will use Microsoft Azure OpenAI Service.

Susquehanna analyst Joseph Stauff maintains Melco Resorts and Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLCO#NASDAQ">MLCO</a>) with a Positive and lowers the price target from $15 to $11.

Analyst Ratings

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

Susquehanna Maintains Positive on Melco Resorts and Enter, Lowers Price Target to $11

TSLA: 14% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38484622">Tesla shares are trading higher on reports the company will partner with Baidu for mapping and navigation for Full Self-Driving in China.</a>
PHG: 46% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38484282">Philips shares are trading higher after the company announced $1.1B settlement for Respironics personal injury and medical monitoring litigation. Reported better than expected Q1 earnings and reaffirmed guidance.</a>
NKGN: 36% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38487726">NKGen Biotech Announces FDA Clearance Of IND Application For SNK01 NK Cell Therapy in Parkinson&#39;s Disease</a>

Movers

NKGN

TSLA

Market-Moving News for April 29th

CAUD

Collective Audience shares are trading higher after the company announced a strategic partnership with Insticator.

Susquehanna analyst Shyam Patil maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Positive and raises the price target from $170 to $225.

GOOGL

Susquehanna Maintains Positive on Alphabet, Raises Price Target to $225

Leerink Partners analyst Mani Foroohar initiates coverage on Neurogene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGNE#NASDAQ">NGNE</a>) with a Outperform rating and announces Price Target of $46.

Initiation

NGNE

Leerink Partners Initiates Coverage On Neurogene with Outperform Rating, Announces Price Target of $46

As the United States becomes more and more politically polarized, one issue stands out as a rare point of <a href="https://www.benzinga.com/cannabis">consensus: cannabis legalization. </a>
In late March 2024, a Pew Research Center survey <a href="https://www.benzinga.com/markets/cannabis/24/03/37964845/9-out-of-10-americans-support-some-form-of-legal-cannabis-pew-research-center-finds">found</a> that an overwhelming share of U.S. adults (88%) believe marijuana should be legal for medical or recreational use, crossing the vast ideological spectrum for which the U.S. has become known.
Despite this widespread public support, neither of the two main presidential contenders, Joe Biden nor Donald Trump, have fully embraced the issue, say advocates.
At the mid-April <a href="https://www.benzinga.com/markets/cannabis/24/04/38305982/cannabis-summit-set-to-shake-up-washington-dc-bipartisan-lawmakers-industry-leaders-rally-for-de">National Cannabis Policy Summit</a> in Washington, DC, one of the organizers Caroline Phillips called the candidates&#8217; track records on cannabis inconsistent and incremental, with promises that have yet to materialize in substantial action. "We&#8217;ve heard promises from both administrations, neither of which have panned out in full," she <a href="https://www.voanews.com/a/cannabis-a-rare-consensus-issue-ahead-of-us-election/7580441.html">told the VOA</a>.
<h2 class="wp-block-heading">But Biden Did This</h2>
Though Biden <a href="https://www.benzinga.com/markets/cannabis/23/08/34120876/health-officials-to-dea-ease-federal-restrictions-on-cannabis-will-this-set-stage-for-legalizati">took a step toward legalization in August 2022</a> by directing the Department of Health and Human Services to review marijuana&#8217;s classification as a controlled substance, advocates are pushing for full removal from the <a href="https://www.benzinga.com/markets/cannabis/24/01/36632145/reschedule-cannabis-or-abolish-the-dea-says-physician-examining-the-50-year-old-trillion-dollar-">DEA&#8217;s Controlled Substances Act</a>, that is to say, fully de-scheduling marijuana. 
Biden seems to be having a difficult time moving beyond his stock phrase that "no one should in prison for cannabis." He even said it <a href="https://www.benzinga.com/markets/cannabis/24/03/37552483/biden-calls-for-cannabis-reform-in-state-of-the-union-a-historic-first-no-one-should-be-jailed-f">during his State of the Union address</a>.
<h2 class="wp-block-heading">And Trump Said That</h2>
Since leaving office, Trump&#8217;s remarks have been hazy, reflecting a mixed position that does not clearly align with either side of the legalization debate. Nearly a year ago, <a href="https://www.benzinga.com/markets/cannabis/23/05/32126730/donald-trump-calls-cannabis-popular-among-voters-though-damaging-still-thinks-dealers-should-get">he called cannabis</a> "a pretty popular thing" from a voting standpoint. Shortly before that, he said <a href="https://www.gunviolencearchive.org/reports/mass-shooting" target="_blank" rel="noreferrer noopener">mass shootings</a> were "not a gun problem&#8221; but rather blamed them on <a href="https://www.benzinga.com/markets/cannabis/23/04/31828477/trump-insinuates-engineered-weed-and-trans-depression-are-responsible-for-mass-shootings-violenc">&#8220;genetically engineered&#8221; cannabis</a>. Trump has <a href="https://www.benzinga.com/markets/cannabis/22/11/29741741/trump-announcement-death-to-drug-dealers-and-beautiful-american-flag-on-mars">called for the death penalty for drug dealers</a> on various occasions.
Morgan Fox, political director for the National Organization for the Reform of Marijuana Laws (NORML) <a href="https://www.voanews.com/a/cannabis-a-rare-consensus-issue-ahead-of-us-election/7580441.html">told the outlet</a> at the DC summit, that Trump has practically avoided the issue of cannabis while on the campaign trail. "We haven&#8217;t heard too much from the Republican nominee so far," he said, calling both of the candidates' attitudes out of step with the vast majority of Americans.  
Fox highlighted the candidates' disconnect from evolving public sentiment around cannabis, saying that despite growing awareness, they've been slow to adapt and therefore risk alienating a significant portion of the electorate, particularly young voters.
"Any candidate that actually wants to get ahead – whether it&#8217;s in the presidential election in Congress or state legislatures or local legislators – if they ignore this issue, it&#8217;s going to be at their peril," Fox said.
Photo: Created with images from&nbsp;<a href="https://www.flickr.com/photos/gageskidmore/" rel="noreferrer noopener" target="_blank">Gage Skidmore</a>&nbsp;on flickr

Cannabis

Government

Politics

Trump And Biden Supporters Are Worlds Apart On Everything Except For This One Issue

Initiative initially focused on generative AI implementation in healthcare claims management, customer service platforms and fraud detection

MSFT

Conduent Collaborates With Microsoft On Generative AI For Drive Innovation In Business Process Solutions

ADXN

Addex shares are trading lower after the company announced the Phase 2 ADX71149 epilepsy study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.

Monday,&nbsp;Koninklijke Philips N.V.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>)&nbsp;<a target="_blank" href="https://www.philips.com/c-dam/corporate/about-philips/investors/financial-results/Philips-Respironics-field-action-progress-update-Mar-2024.pdf" rel="noreferrer noopener">said</a>&nbsp;it reached a $1.1 billion settlement in the U.S. related to the recall of its Respironics ventilators.
Philips and the plaintiffs&#8217; leadership, through a Court-appointed mediator, have reached an agreement to resolve the personal injury litigation and the medical monitoring class action in the U.S.
The settlement addresses ~58,000 individuals who filed a claim or entered the census registry.
Philips and Philips Respironics do not admit fault, liability, or any injuries caused by the devices.
Philips Respironics has agreed to pay the capped total of&nbsp;$1.1 billion&nbsp;(covering all costs); the related payments are expected in 2025 and will&nbsp;be funded&nbsp;from the company&#8217;s cash flow generation.
Consequently, a 982 million euro provision was <a href="https://www.benzinga.com//node/38481198">recognized in the first quarter.</a>
Philips also agreed with insurers to pay Philips 540 million euros to cover Respironics recall-related product liability claims. This income is expected to&nbsp;be recognized&nbsp;in the second quarter of 2024, and payment&nbsp;is expected&nbsp;in 2024.
Recently, Philips Respironics signed a consent decree and obtained the final court approval for the previously announced economic loss&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/04/38183401/why-is-european-healthcare-tech-giant-philips-stock-trading-higher-on-wednesday" rel="noreferrer noopener">settlement in the U.S.</a>
Philips&nbsp;reported first-quarter sales of $4.49 billion, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $4.46 billion</a>.
Comparable sales increased 2.4%, driven by growth in the Diagnosis &amp; Treatment and Personal Health segments, partly offset by a decline in Connected Care.
The company&nbsp;<a target="_blank" href="https://www.philips.com/a-w/about/news/archive/corpcomms/news/press/2024/philips-first-quarter-results-2024.html" rel="noreferrer noopener">reported</a>&nbsp;adjusted EPS of $0.28, which is&nbsp;in line with the consensus of $0.28.
Adjusted EBITA improved to 388 million euros&nbsp;and&nbsp;the margin increased to 9.4%, driven by productivity and pricing actions.
Comparable&nbsp;order intake fell due to slower sales in China and was 3.8% lower during the quarter.
Guidance:&nbsp;For 2024, Philips reiterates its comparable sales growth of 3%-5%, with an adjusted&nbsp;EBITA&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/g38481198/philips-delivers-first-quarter-results-in-line-with-2024-performance-improvement-plan-resolves-the" rel="noreferrer noopener">margin of 11%-11.5%</a>.
The expected free cash flow is now increased to 0.9-1.1 billion euros&nbsp;in 2024, including the receipt from insurers for the Respironics product liability claims and the remaining payment related to the economic loss settlement.&nbsp;
The personal injury and medical monitoring litigation settlement payment&nbsp;is expected&nbsp;in 2025.
Price Action: PHG shares are up 36.7% at $28.80 during the premarket session at the last check Monday.
Photo via Wikimedia Commons

Earnings

Equities

Guidance

Health Care

Legal

General

Philips Reaches $1.1B Settlement On US Sleep Apnea Devices' Claims, Backs Annual Guidance

Stifel analyst J. Bruce Chan maintains Landstar System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTR#NASDAQ">LSTR</a>) with a Hold and lowers the price target from $166 to $164.

LSTR

Stifel Maintains Hold on Landstar System, Lowers Price Target to $164

Stifel analyst Frank Galanti maintains FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) with a Hold and raises the price target from $59 to $66.

FTAI

Stifel Maintains Hold on FTAI Aviation, Raises Price Target to $66

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/04/26/final-trades-netflix-jpmorgan-nasdaq-etf-delta-leidos.html">Halftime Report Final Trades</a>,&#8221; Joshua Brown of Ritholtz Wealth Management says selling in Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) stock was overdone. 
On April 18, Netflix reported upbeat earnings and sales results for its first quarter. The company added 9.33 million paid net new subscribers in the first quarter to bring the company to a total of 269.60 million.
Bryn Talkington of Requisite Capital Management named JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JEPQ#NASDAQ">JEPQ</a>) as her final trade.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Jim Lebenthal of Cerity Partners named Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>).
On April 10, Delta Air Lines reported better-than-expected first-quarter earnings. Delta reported a first-quarter 2024 operating revenue growth of 8% year-over-year to $13.748 billion and adjusted operating revenue of $12.563 billion (+6% YoY), beating the consensus of $12.57 billion. Adjusted EPS was 45 cents, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38208241/delta-air-lines-on-line-to-gain-demand-growth-says-bofa-analyst">above the consensus of 36 cents</a>.
Stephen Weiss of Short Hills Capital Partners picked Leidos Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>).
On April 15, the U.S. Army awarded Leidos a $267 million systems task order. The company will announce its first quarter 2024 financial results on April 30.
Price Action:
<ul>
<li>Netflix shares fell 0.6% to close at $561.23 on Friday.</li>
<li>JPMorgan Nasdaq Equity Premium Income ETF gained 1.4% during Friday's session.</li>
<li>Leidos Holdings shares rose 0.4% to close at $130.36 during Friday's session.</li>
<li>Delta Air Lines shares gained 0.1% to settle at $49.92 on Friday.</li>
</ul>
Now Read: <a href="https://www.benzinga.com/news/earnings/24/04/38482010/dominos-pizza-yum-china-and-3-stocks-to-watch-heading-into-monday">Domino&#8217;s Pizza, Yum China And 3 Stocks To Watch Heading I</a><a href="https://www.benzinga.com/news/earnings/24/04/38482010/dominos-pizza-yum-china-and-3-stocks-to-watch-heading-into-monday">nto Monday</a>
Image: Shutterstock

Long Ideas

Media

JEPQ

LDOS

NFLX

Netflix, Leidos, Delta Air Lines And More On CNBC's 'Final Trades'

SAIA

Saia shares are trading higher, possibly rebounding after the stock fell last week on worse-than-expected Q1 financial results.

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) has been struggling to maintain its bullish momentum in recent weeks, raising concerns among traders about <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38471459/bitcoin-ethereum-dogecoin-on-shaky-ground-crypto-veteran-sees-bitcoin-still-stuck-in-range">its short-term prospects</a>. 
What Happened: Cryptocurrency trader Kevin, formerly known as OG_Yomi, in a recent <a href="https://twitter.com/Kev_Capital_TA/status/1784731797529534466">tweet</a>, expressed his disappointment with Dogecoin&#8217;s performance, stating, &#8220;Unfortunately Dogecoin could not get the bounce back week we were looking for and in fact is now closing its lowest weekly candle in almost 2 months.&#8221;
The trader suggests that a retest of the $0.125 to $0.13 level now seems likely, emphasizing that this is a crucial support level that must hold for Dogecoin to maintain its bullish outlook. A breach of this level could potentially lead to further downside pressure on the cryptocurrency&#8217;s price.
However, in another <a href="https://twitter.com/Kev_Capital_TA/status/1784732883560620105">tweet</a>, he clarified that his short-term analysis should not be confused with his long-term perspective on Dogecoin. He acknowledges that in the immediate future, spanning the next two to three weeks, he leans towards a bearish or choppy price action for the meme coin.
Despite the short-term challenges, Kevin remains optimistic about Dogecoin&#8217;s long-term prospects. &#8220;Obviously I wouldn&#8217;t be holding if I thought it was all over,&#8221; he asserts, indicating his confidence in the cryptocurrency&#8217;s potential for growth over the next six to eight months.
Price Action: At the time of writing, DOGE was trading at $0.1409, down 5.6% over the past 24 hours, taking its monthly loss to 33.5%. Despite the fall in prices, trading volume in the past 24 hours increased by 13.2%.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38460505/are-dogecoin-and-shiba-inu-primed-for-the-next-leg-up">Are Dogecoin And Shiba Inu Primed For The Next Leg Up?</a>
Why It Matters: IntoTheBlock data indicates a surge of 19.6% in large transaction volume to $853 million, while daily active addresses increased by 2.6% to 54,640.
With mounting monthly losses (33.5%), 80% of Dogecoin holders are in profit, down from prior week's 83%. Concentration by large holders stands at 63% and transactions greater than $100,000 saw a marginal increase to 266 transactions as of April 28 from 250 as of April 27.
Santiment feed data shows Dogecoin wallets with a non-zero balanced increased by 13.8%, implying sustained interest in the meme coin despite consolidation in prices. 
Kevin's long-term bullish stance on Dogecoin suggests that patient investors who can weather the current uncertainty may be rewarded in the months ahead.
What's Next: The influence of meme coins and&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;are topics expected to be thoroughly explored at Benzinga's upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38469336/meme-coins-are-a-pure-ponzi-and-destroying-crypto-says-trader-who-thinks-dogecoin-was-diff">Meme Coins Are &#8216;A Pure Ponzi&#8217; And &#8216;Destroying Crypto,&#8217; Says Trader Who Thinks Dogecoin Was Different</a>
Image: Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

Dogecoin's 5% Loss Closes Lowest Weekly Candle In 2 Months, But This Trader 'Wouldn't Be Holding If It Was All Over'

Stifel analyst Mark Astrachan maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Buy and raises the price target from $94 to $95.

Stifel Maintains Buy on Colgate-Palmolive, Raises Price Target to $95

KINS

Kingstone Companies Sees Prelim. Q1 2024 Net Premiums Earned $28.8M, Up 2.0% YoY; Net Premiums Earned From Non-Core Business Down 49% From $4.5M To $2.3M YoY

Jefferies analyst Laurence Alexander upgrades Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) from Hold to Buy and raises the price target from $102 to $125.

Upgrades

Jefferies Upgrades Eastman Chemical to Buy, Raises Price Target to $125

Shopify shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised its price target from $93 to $105.

The Low-Volatility Factor And Occam's Razor

Lessons From The Past On How To Position Equity Portfolios In A U.S. Presidential Election Year

Designing Multi-Asset Income: It's Complementary

SPLV And USMV Have Different Views On Volatility, So Which Is Better?

Growing Divergences In Small Vs. Large Caps

SPDR SSGA US Large Cap Low Volatility Index ETF declares quarterly distribution of $0.6444